News
Though the renal protection provided by antihypertensive doses of ACE inhibitors and ARBs has been extensively studied, the dose response of these agents may be different for renal protection.
In conclusion, our short-term study supports the concept that treatment with both ACE-I and ARB offer synergistic renoprotection not obtainable with maximal recommended doses of ACEI in type 2 ...
This medication is an angiotensin II receptor blocker (ARB), prescribed for high blood pressure either alone or combined with other medications. This medication is an angiotensin II receptor ...
In fact, the antiproteinuric effects of ACE inhibitors and ARBs plateau at doses exceeding those at which the maximum antihypertensive effect is observed. Emphasis on the results of the above ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results